Intravenous immunoglobulin (IVIG) has been used primarily for immune deficiency patients, and its greatest expansion is seen more and more in the treatment of autoimmune disorders, especially in neurology. The benefits of IVIG treatment include its availability in all treatment centers and its ease of administration in an outpatient setting. This article gives an overview of some autoimmune neurologic diseases and explores the clinical evidence supporting the use of IVIG.
机构:
Univ New S Wales, Fac Med, Sydney, NSW 2052, AustraliaUniv New S Wales, St George Hosp, Dept Dermatol, Sydney, NSW 2217, Australia
Chee, Shien-Ning
Murrell, Dedee F.
论文数: 0引用数: 0
h-index: 0
机构:
Univ New S Wales, St George Hosp, Dept Dermatol, Sydney, NSW 2217, AustraliaUniv New S Wales, St George Hosp, Dept Dermatol, Sydney, NSW 2217, Australia
机构:
Univ New S Wales, St George Hosp, Dept Dermatol, Sydney, NSW 2217, Australia
Univ New S Wales, Fac Med, Sydney, NSW 2052, AustraliaUniv New S Wales, St George Hosp, Dept Dermatol, Sydney, NSW 2217, Australia
Chee, Shien-Ning
Murrell, Dedee F.
论文数: 0引用数: 0
h-index: 0
机构:
Univ New S Wales, St George Hosp, Dept Dermatol, Sydney, NSW 2217, AustraliaUniv New S Wales, St George Hosp, Dept Dermatol, Sydney, NSW 2217, Australia